Risk factors for lower limb deep vein thrombosis after thoracic surgery: a retrospective single-center study

胸外科手术后下肢深静脉血栓形成的危险因素:一项回顾性单中心研究

阅读:1

Abstract

PURPOSE: This study aims to determine the incidence of lower limb deep vein thrombosis (DVT) after thoracic surgery and explore its association with coagulation indicators. METHODS: A retrospective analysis was conducted on 114 patients who underwent thoracic surgery and received mechanical prophylaxis (e.g., compression stockings) from April to June 2025. Cases with complete data on lower limb venous ultrasound, blood routine, conventional coagulation tests(prothrombin time, International normalized ratio, Activated partial thromboplastin time, Fibrinogen, Thrombin time), and were included in the study. The study analyzed the general information, surgical methods, pathology, and coagulation indicators of patients who developed thrombosis. RESULTS: A total of 114 patients were included, ranging in age from 16 to 84 years, with 64 males and 50 females. Among them, 28 patients (24.56%) developed calf deep vein thrombosis, with postoperative DVT rate of 21.88% (14/64) in males and 28.00% (14/50) in females. The DVT incidence in patients with malignant tumors was 27.14% (19/70), while it was 20.46% (9/44) in those without malignant tumors. The incidence of smoking history was 14.29% (5/35), and the incidence without smoking history was 29.11% (23/79). The BMI, platelet count, conventional coagulation tests, and were compared between the groups that developed thrombosis and those that did not. Significant differences were observed in age and thrombelastogram(TEG) parameters(e.g., R, K,α Angle, MA) between the two groups, while no other factors showed statistical significance. CONCLUSION: Despite mechanical prophylaxis, lower limb DVT remains common after thoracic surgery, particularly among women and patients with malignancies. Age and TEG parameters showed predictive value, underscoring the need for postoperative ultrasound screening and potential consideration of pharmacologic prophylaxis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13019-025-03821-z.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。